MechanismsHumans
Whole Blood Gene Expression Network Expression Strongly Relates to Plasma pTau217 Levels
AAIC 2025 Abstract
Abstract
Background: pTau217 is a well validated plasma biomarker for Alzheimer's disease (AD), sensitive to the accumulation of amyloid pathology in the preclinical stages of disease.
The paper
Vaibhav A. Janve, Mabel Seto, Hannah M Klinger, A4 and LEARN Study Group
Show 8 more authors
Jane A. Brown, Reisa Anne Sperling, Paul S. Aisen, Robert A. Rissman, Mary Ellen I. Koran, Logan C. Dumitrescu, Rachel F. Buckley, Timothy J. Hohman,Vanderbilt University Medical Center
AAIC 2025 Abstract · 23 Dec 2025 · CC BY
Presented at AAIC 2025
